相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Vitamin D3 administration to MS patients leads to increased serum levels of latency activated peptide (LAP) of TGF-beta
Julia Aivo et al.
JOURNAL OF NEUROIMMUNOLOGY (2015)
Vitamin D status and effect of interferon-β1a treatment on MRI activity and serum inflammation markers in relapsing-remitting multiple sclerosis
Egil Rosjo et al.
JOURNAL OF NEUROIMMUNOLOGY (2015)
Environmental risk factors and multiple sclerosis: an umbrella review of systematic reviews and meta-analyses
Lazaros Belbasis et al.
LANCET NEUROLOGY (2015)
Ultraviolet B Light Attenuates the Systemic Immune Response in Central Nervous System Autoimmunity
Johanna Breuer et al.
ANNALS OF NEUROLOGY (2014)
Increasing serum levels of vitamin A, D and E are associated with alterations of different inflammation markers in patients with multiple sclerosis
Egil Rosjo et al.
JOURNAL OF NEUROIMMUNOLOGY (2014)
Vitamin D status and the risk of multiple sclerosis: A systematic review and meta-analysis
Shurong Duan et al.
NEUROSCIENCE LETTERS (2014)
Vitamin D as an Early Predictor of Multiple Sclerosis Activity and Progression
Alberto Ascherio et al.
JAMA NEUROLOGY (2014)
Vitamin D status and ill health: a systematic review
Philippe Autier et al.
LANCET DIABETES & ENDOCRINOLOGY (2014)
Vitamin D supplementation for patients with multiple sclerosis treated with interferon-beta: a randomized controlled trial assessing the effect on flu-like symptoms and immunomodulatory properties
Daniel Golan et al.
BMC NEUROLOGY (2013)
Interdependence and contributions of sun exposure and vitamin D to MRI measures in multiple sclerosis
Robert Zivadinov et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2013)
The effect of vitamin D-related interventions on multiple sclerosis relapses: a meta-analysis
Eleanor James et al.
MULTIPLE SCLEROSIS JOURNAL (2013)
A Systematic Review of Randomized, Double-Blind, Placebo-Controlled Trials Examining the Clinical Efficacy of Vitamin D in Multiple Sclerosis
Beatriz Pozuelo-Moyano et al.
NEUROEPIDEMIOLOGY (2013)
Inflammation Markers in Multiple Sclerosis: CXCL16 Reflects and May Also Predict Disease Activity
Trygve Holmoy et al.
PLOS ONE (2013)
Effects of ultraviolet light on human serum 25-hydroxyvitamin D and systemic immune function
Sarah V. I. Milliken et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
CXCL16 Orchestrates Adenosine A3 Receptor and MCP-1/CCL2 Activity to Protect Neurons from Excitotoxic Cell Death in the CNS
Maria Rosito et al.
JOURNAL OF NEUROSCIENCE (2012)
Effect of vitamin D3 supplementation on relapses, disease progression, and measures of function in persons with multiple sclerosis: exploratory outcomes from a double-blind randomised controlled trial
Margitta T. Kampman et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
Vitamin D and disease activity in multiple sclerosis before and during interferon-β treatment
Kristin I. Loken-Amsrud et al.
NEUROLOGY (2012)
Interferon-β and serum 25-hydroxyvitamin D interact to modulate relapse risk in MS
Niall Stewart et al.
NEUROLOGY (2012)
The effects of vitamin D repletion on endothelial function and inflammation in patients with coronary artery disease
Seth I. Sokol et al.
VASCULAR MEDICINE (2012)
Therapeutic Effect of Vitamin D3 in Multiple Sclerosis Patients
Ghasem Mosayebi et al.
IMMUNOLOGICAL INVESTIGATIONS (2011)
Can vitamin D3 supplementation prevent bone loss in persons with MS? A placebo-controlled trial
Linn H. Steffensen et al.
JOURNAL OF NEUROLOGY (2011)
Sun exposure and vitamin D are independent risk factors for CNS demyelination
R. M. Lucas et al.
NEUROLOGY (2011)
Modulation of the immune system by UV radiation: more than just the effects of vitamin D?
Prue H. Hart et al.
NATURE REVIEWS IMMUNOLOGY (2011)
Is hypovitaminosis D one of the environmental risk factors for multiple sclerosis?
Charles Pierrot-Deseilligny et al.
BRAIN (2010)
No effect of supplementation with cholecalciferol on cytokines and markers of inflammation in overweight and obese subjects
Rolf Jorde et al.
CYTOKINE (2010)
Effect of smoking on the serum levels of 25-hydroxyvitamin D depends on the assay employed
Guri Grimnes et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2010)
A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis
J. M. Burton et al.
NEUROLOGY (2010)
Safety and T Cell Modulating Effects of High Dose Vitamin D3 Supplementation in Multiple Sclerosis
Joost Smolders et al.
PLOS ONE (2010)
Vitamin D and Serum Cytokines in a Randomized Clinical Trial
Eleanor Yusupov et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2010)
Vitamin D Status Is Positively Correlated with Regulatory T Cell Function in Patients with Multiple Sclerosis
Joost Smolders et al.
PLOS ONE (2009)
Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis
J. Smolders et al.
MULTIPLE SCLEROSIS JOURNAL (2008)
Cytokine profile in patients with multiple sclerosis following vitamin D supplementation
BD Mahon et al.
JOURNAL OF NEUROIMMUNOLOGY (2003)
分享论文
